Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA Gains 7%; BSE HEALTHCARE Index Down 0.0%
Thu, 28 Nov 9:56

BLISS GVS PHARMA Gains 7%; BSE HEALTHCARE Index Down 0.0%Image source: ipopba/www.istockphoto.com

BLISS GVS PHARMA share price has zoomed 7% and is presently trading at Rs 151.5.

Meanwhile, the BSE HEALTHCARE index is at 42,990.8 .

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 1.9%) and CAPLIN POINT (up 1.4%).

AJANTA PHARMA (down 1.9%) and KIMS (down 1.9%) are among the top losers today.

Over the last one year, BLISS GVS PHARMA has moved up from Rs 144.6 to Rs 151.5, registering a gain of Rs 6.9 (up 4.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 42,990.8, registering a gain of 45.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.8%), Glenmark Pharma (up 96.9%) and SUVEN PHARMACEUTICALS (up 94.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,248.8 .

The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 1.4%) and HDFC Bank (up 1.2%). The most traded stocks in the BSE Sensex are MUNDRA PORT & SEZ and Axis Bank.

In the meantime, NSE Nifty is at 24,296.5 (up 0.1%). Adani Enterprises and Shriram Transport are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 80,248.8, registering a gain of 14,074.6 points (up 21.3%).

BLISS GVS PHARMA Financial Update...

BLISS GVS PHARMA net profit fell 40.3% YoY to Rs 257 million for the quarter ended September 2024, compared to a profit of Rs 430 million a year ago. Net sales rose 2.7% to Rs 2,177 million during the period as against Rs 2,119 million in July-September 2023.

For the year ended March 2024, BLISS GVS PHARMA reported 6.3% increase in net profit to Rs 816 million compared to net profit of Rs 767 million during FY23. Revenue of the company grew 2.5% to Rs 7,702 million during FY24.

The current Price to earnings ratio of BLISS GVS PHARMA, based on rolling 12 month earnings, stands at 22.2.


Equitymaster requests your view! Post a comment on "BLISS GVS PHARMA Gains 7%; BSE HEALTHCARE Index Down 0.0%". Click here!